Simvastatin (Sim) v placebo in patients at high risk of vascular disease*
| Outcomes at 5 years | Sim | Placebo | RRR (95% CI) | NNT (CI) |
|---|---|---|---|---|
| *Abbreviations defined in glossary; NNT and CI calculated from control event rate and rate ratio in article. | ||||
| †Non-fatal myocardial infarction or coronary death, stroke, or revascularisation procedure. | ||||
| ⩾1 major vascular event† | 20% | 25% | 24% (19 to 28) | 17 (15 to 21) |
| ⩾1 stroke | 4.3% | 5.7% | 25% (15 to 34) | 71 (52 to 117) |
| ⩾1 ischaemic stroke | 2.8% | 4.0% | 30% (19 to 40) | 84 (63 to 133) |